- Home
- LULU vs TAK Comparison
LULU vs TAK Comparison
Compare LULU & TAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LULU
- TAK
- Stock Information
- Founded
- LULU 1998
- TAK 1781
- Country
- LULU Canada
- TAK Japan
- Employees
- LULU N/A
- TAK N/A
- Industry
- LULU Apparel
- TAK Biotechnology: Pharmaceutical Preparations
- Sector
- LULU Consumer Discretionary
- TAK Health Care
- Exchange
- LULU Nasdaq
- TAK Nasdaq
- Market Cap
- LULU 45.5B
- TAK 42.2B
- IPO Year
- LULU 2007
- TAK N/A
- Fundamental
- Price
- LULU $358.97
- TAK $14.07
- Analyst Decision
- LULU Buy
- TAK
- Analyst Count
- LULU 28
- TAK 0
- Target Price
- LULU $408.81
- TAK N/A
- AVG Volume (30 Days)
- LULU 1.5M
- TAK 1.7M
- Earning Date
- LULU 03-20-2025
- TAK 01-30-2025
- Dividend Yield
- LULU N/A
- TAK 3.63%
- EPS Growth
- LULU 76.60
- TAK 15.39
- EPS
- LULU 13.87
- TAK 0.83
- Revenue
- LULU $10,181,732,000.00
- TAK $29,124,927,177.00
- Revenue This Year
- LULU $11.79
- TAK $6.36
- Revenue Next Year
- LULU $6.96
- TAK $0.55
- P/E Ratio
- LULU $25.68
- TAK $33.76
- Revenue Growth
- LULU 10.84
- TAK 9.83
- 52 Week Low
- LULU $226.01
- TAK $12.58
- 52 Week High
- LULU $480.94
- TAK $15.08
- Technical
- Relative Strength Index (RSI)
- LULU 32.61
- TAK 64.16
- Support Level
- LULU $354.05
- TAK $13.66
- Resistance Level
- LULU $374.41
- TAK $13.97
- Average True Range (ATR)
- LULU 12.62
- TAK 0.13
- MACD
- LULU -6.14
- TAK 0.06
- Stochastic Oscillator
- LULU 7.70
- TAK 96.15
About LULU lululemon athletica inc.
Lululemon Athletica designs, distributes, and markets athletic apparel, footwear, and accessories for women, men, and girls. Lululemon offers pants, shorts, tops, and jackets for both leisure and athletic activities such as yoga and running. The company also sells fitness accessories, such as bags, yoga mats, and equipment. Lululemon sells its products through more than 700 company-owned stores in about 20 countries, e-commerce, outlets, and wholesale accounts. The company was founded in 1998 and is based in Vancouver, Canada.
About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.3 trillion in fiscal 2023. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the US, 20% from Japan, 20% from Europe and Canada.